What it sells
NuSynth is an R&D-led process innovation platform that redesigns synthesis routes for complex chemistry (pharmaceutical and electronic chemicals) using fewer steps, safer reagents and an AI-enabled R&D knowledge base.
Business model breakdown
Distribution: how it reaches customers
Project-based; 'Discuss a Project'; scales through 20+ verified manufacturing partners.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-10-14 | Seed | 36.5cr | — | news.google.com |
| 2026-10-14 | — | ₹36.5 Crore | — | news.google.com |
| 2026-10-13 | Seed | ₹36 cr | — | news.google.com |
| 2026-10-13 | Seed | ₹36.5 crore | — | news.google.com |
| 2026-10-13 | — | Rs 36.5 crore | Avaana Capital (lead), Shastra VC (lead) | news.google.com |
| 2026-10-13 | — | Rs 36.5 crore | Avaana Capital (lead), Shastra VC (lead) | news.google.com |
| 2026-10-13 | — | ₹36.5 Cr | Avaana Capital, Shastra VC | inc42.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-17.